Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BM.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.46NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CA.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.83NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.161NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.58NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.75NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.411NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.217NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.17 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.41NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.527NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.500NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.147NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.487NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.68NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AS.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.127.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CA.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BM.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.46NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CU.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CA.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.40NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.2.4 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.161NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.58NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.75NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.411NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.217NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.35NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.17 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.41NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.527NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.18NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.500NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.147NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.487NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.68NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.121NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AA.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used